Isolate Data
| Patient | Isolate | Region | Year | Species | Subtype | Source | Clone Method |
| MV-210 | MV-210wk12 | U.K. | 1995 | HIV1 | B | Plasma | None |
Treatment History
| Order | Regimen | Weeks |
| 1 | ABC | 12 |
RT Sequence
| NRTIMajorDRMs | NRTIMinorDRMs | NNRTIMajorDRMs | NNRTIMinorDRMs | Polys | UnusualMuts |
| L74LV | K49R, S68G, K122E, E169D, I178L, Q207QK, D218X |
| >MV-210wk12| codons 30-219 KIKALVEICTEMEKEGKISRIGPENPYNTPVFAIKKKDGTKWRKVVDFRELNKRTQDFWE VQLGIPHPAGLKKKKSVTVLDVGDAYFSVPLDEDFRKYTAFTIPSINNETPGIRYQYNVL PQGWKGSPAIFQSSMTKILDPFRKQNPDLVIYQYMDDLYVGSDLEIGQHRTKIEELRKHL LRWGFTTPXK |
References
| Author | Title | Citation |
| Miller, V | HIV-1 reverse transcriptase (RT) genotype and susceptibility to RT inhibitors during abacavir monotherapy and combination therapy. | AIDS, 2000 |
| Rhee, SY | HIV-1 protease and reverse transcriptase mutations: Correlations with antiretroviral therapy in subtype B isolates and implications for drug-resistance surveillance. | J Infect Dis, 2005 |